LAG-3 dampens CD4+ T cell activation by disrupting CD3ε-Lck condensates and is a therapeutic target in both cancer and autoimmunity.
A LAGging kiss leaves T cells cold | Science Immunology
LAG-3 dampens CD4+ T cell activation by disrupting CD3ε-Lck condensates and is a therapeutic target in both cancer and autoimmunity.